According to recent study, at least 17 million people in the European Union may have endured protracted COVID-19 symptoms during the first two years of the coronavirus pandemic, with women being more likely to encounter the condition than males, the World Health Organization reported on Tuesday.
According to the study, it was not obvious whether persons who had had vaccinations or those who hadn’t were more likely to experience symptoms that persisted, returned, or appeared at least a month after a coronavirus infection. According to the analysis, at least 17 million people in 2020 and 2021 had long COVID-19 symptoms that lasted at least three months.
According to the findings, modelling also indicates that women are twice as likely as males to develop protracted COVID-19, and the risk rises sharply among serious infections requiring hospitalisation. According to the findings, long COVID-19 is predicted to emerge in one in three women and one in five men.
The study, which uses estimates rather than actual numbers of patients, is consistent with certain other recent investigations into the pattern of long-term symptoms following coronavirus infections.
New findings from a U.S. research of veterans published in Nature Medicine in May showed that older adults are more at risk for long-term COVID-19 effects than younger adults and that these effects can occur even after breakthrough infections in people who have received vaccinations. According to the study, almost one-third of patients with breakthrough infections had lengthy COVID.
According to a different report from the Centers for Disease Control and Prevention, 1 in 4 persons 65 and older had at least one probable long-term COVID-19 health concern up to a year after contracting the coronavirus, compared to 1 in 5 younger adults.
The majority of COVID-19 patients recover completely. However, the WHO in Europe research on Tuesday predicted that 10% to 20% have mid- to long-term symptoms such weariness, shortness of breath, and cognitive impairment.
